Government denies pressures from U.S. negotiators over new drug pricing and FTA talks

Published: 2006-08-01 07:00:00

Updated: 2006-08-01 07:00:00

During the second round of negotiations for a proposed Korea-U.S. free trade agreement (FTA), there was no pressure from the United States on the Korean government to give up drug pricing reform or delay its introduction to protect the interest of American drug manufacturers in the Korean market ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK